Vita-D 200,000IU
Category
IV Therapy
Origin
Korea
Interested in ordering Vita-D 200,000IU? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Vita-D 200,000 IU is a Korean cholecalciferol (vitamin D3) injectable containing 5 mg (200,000 IU) per ampoule, used for the prevention and treatment of vitamin D deficiency in adults. It is administered by intramuscular injection under medical supervision and is typically supplied in boxes of 5 or 10 ampoules. The specific manufacturer is not independently confirmed in available trade listings.
How it works
Cholecalciferol (vitamin D3) is converted in the liver to 25-hydroxyvitamin D and then in the kidney to the active hormone calcitriol, which regulates intestinal calcium and phosphate absorption and bone mineralisation. A single high-dose intramuscular depot raises and sustains serum 25(OH)D levels, correcting deficiency where oral repletion is impractical or adherence is poor. It addresses nutrient status rather than acting as a skin-brightening agent.
Indications
- Prevention and treatment of vitamin D deficiency in adults
- Repletion where oral supplementation is impractical or poorly tolerated
- Bone-health and musculoskeletal support programs
- General wellness / nutrient-status optimisation
- Adjunct nutrient support in broader wellness protocols
Key features
- High-dose cholecalciferol depot: 200,000 IU (5 mg) per ampoule
- Single intramuscular dose for rapid repletion
- Convenient alternative to daily oral supplementation
- Compact ampoule presentation (5-10 per box)
- Supports adherence in deficiency management
Benefits
- Corrects vitamin D deficiency where oral adherence is poor
- Single-dose depot simplifies repletion regimens
- Extends clinic wellness / nutrient offerings beyond aesthetics
- Objective, testable endpoint (serum 25(OH)D) for follow-up
- Long shelf-stable ampoule format for inventory
Composition
Cholecalciferol (vitamin D3) 5 mg = 200,000 IU per ampoule (1 mL).
Usage & handling
Prescription injectable administered intramuscularly by a clinician; high-dose vitamin D should be dosed on the basis of baseline serum 25(OH)D and clinical need to avoid hypervitaminosis D and hypercalcaemia. Take a history for hypercalcaemia, hypercalciuria, nephrolithiasis, sarcoidosis/granulomatous disease and renal impairment, and avoid stacking with other high-dose vitamin D sources. Monitor calcium and 25(OH)D on repeat dosing and observe for injection-site reactions.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.